Danaher (NYSE:DHR) Issues Quarterly Earnings Results

Danaher (NYSE:DHR) issued its quarterly earnings results on Tuesday. The conglomerate reported $2.11 EPS for the quarter, topping analysts’ consensus estimates of $1.92 by $0.19, FiscalAI reports. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The company had revenue of $6.55 billion during the quarter, compared to analyst estimates of $6.56 billion. During the same period in the previous year, the company earned $1.89 earnings per share. The company’s quarterly revenue was up 8.3% compared to the same quarter last year.

Danaher Price Performance

Shares of DHR stock opened at $224.78 on Wednesday. The firm has a market cap of $158.02 billion, a price-to-earnings ratio of 39.93, a PEG ratio of 2.82 and a beta of 0.76. Danaher has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The stock has a 50-day moving average price of $214.70 and a 200 day moving average price of $196.54.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s payout ratio is currently 28.42%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. TD Cowen raised their price objective on shares of Danaher from $236.00 to $255.00 and gave the stock a “buy” rating in a research note on Tuesday, October 13th. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Sunday. Stifel Nicolaus decreased their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Morgan Stanley increased their target price on Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a report on Monday, October 12th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $235.41.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.